Associated Papers
Concomitant EML4-ALK rearrangement and EGFR mutation in non-small cell lung cancer patients: a literature review of 100 cases.
Lo Russo G et al.
Oncotarget, 2017
Responses to crizotinib and chemotherapy in patients with lung adenocarcinoma harboring a concomitant EGFR mutation and ALK gene rearrangement: A case report and review of the literature.
Li Y et al.
Molecular and Clinical Oncology, 2017
K-RAS mutations indicating primary resistance to crizotinib in ALK-rearranged adenocarcinomas of the lung: Report of two cases and review of the literature.
Mengoli MC et al.
Lung Cancer (amsterdam, Netherlands), 2016
Concurrent EGFR Mutation and ALK Translocation in Non-Small Cell Lung Cancer.
Sweis RF et al.
Cureus, 2016
Select a paper to view details